Proteomic analysis of chromium cytotoxicity in cultured rat lung epithelial cells

Proteomics

Volumn 8, Issue 12, 2008, Pages 2420-2429

  Lei, Ting ^a   He, Qing Yu ^b   Cai, Zhen ^c   Zhou, Yuan ^c   Wang, Yi Li ^a   Si, Lu Sheng ^a   Cai, Zongwei ^d   Chiu, Jen Fu ^c  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Chromium; Cytotoxicity; Reactive oxygen species; Subcellular proteomics

Indexed keywords

CHROMIUM; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CARCINOGENESIS; CELL CULTURE; CYTOTOXICITY; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RAT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL LINE; CHROMIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FLUORESCENT DYES; INDOLES; LUNG; NAPHTHOLS; OXIDATIVE STRESS; PEPTIDE MAPPING; PROTEOMICS; RATS; REACTIVE OXYGEN SPECIES; SILVER STAINING; SUBCELLULAR FRACTIONS; TIME FACTORS;

RATTUS;

EID: 48249095483     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200701050     Document Type: Article

References (39)

1. Langard, S., One hundred years of chromium and cancer: A review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 1990, 17, 189-215.
2. Alcedo, J. A., Wetterhahn, K. E., Chromium toxicity and carcinogenesis. Int. Rev. Exp. Pathol. 1990, 31, 85-108.
3. Dillon, C. T., Lay, P. A., Kennedy, B. J., Stampfl, A. P. et al., Hard X-ray microprobe studies of chromium(VI)-treated V79 Chinese hamster lung xells: Intracellular mapping of the biotransformation products of a chromium carcinogen. J. Biol. Inorg. Chem. 2002, 7, 640-645.
4. Aiyar, J., De Flora, S., Wetterhahn, K. E., reduction of chromium(VI) to chromium(V) by rat liver cytosolic and microsomal fractions: Is DT-diaphorase involved? Carcinogenesis 1992, 13, 1159-1166.
5. Standeven, A. M., Wetterhahn, K. E., Ascorbate is the principal reductant of chromium (VI) in rat liver and kidney ultrafiltrates. Carcinogenesis 1991, 12, 1733-1737.
6. Wiegand, H. J., Ottenwalder, H., Bolt, H. M., The reduction of chromium (VI) to chromium (III) by glutathione: an intracellular redox pathway in the metabolism of the carcinogen Chromate. Toxicology 1984, 33, 341-348.
7. Shi, X., Chiu, A., Chen, C. T., Halliwell, B. et al., Reduction of chromium(VI) and its relationship to carcinogenesis. J. Toxicol. Environ. Health B Crit. Rev. 1999, 2, 87-104.
8. Shackelford, R. E., Kaufmann, W. K., Paules, R. S., Cell cycle control, checkpoint mechanisms, and genotoxic Stress. Environ. Health Perspect. 1999, 107, 5-24.
9. Dillon, C. T., Lay, P. A., Bonin, A. M., Cholewa, M. et al., Permeability, cytotoxicity, and genotoxicity of Cr(III) complexes and some Cr(V) analogues in V79 Chinese hamster lung cells. Chem. Res. Toxicol. 2000, 13, 742-748.
10. Sugden, K. D., Geer, R. D., Rogers, S. J., Oxygen radical-mediated DNA damage by redox-active Cr(III) complexes. Biochemistry 1992, 31, 11626-11631.
11. Xu, J., Bubley, G. J., Detrick, B., Blankenship, L. J. et al., Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle. Carcinogenesis 1996, 17, 1511-1517.
12. Singh, J., Carlisle, D. L., Pritchard, D. E., Patierno, S. R., Chromium-induced genotoxicity and apoptosis: Relationship to chromium carcinogenesis (review). Oncol. Rep. 1998, 5, 1307-1318.
13. De Flora, S., Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis 2000, 21, 533-541.
14. Li, M., Cai, J. F., Chiu, J. F., Arsenic induces oxidative stress and activates stress gene expressions in cultured lung epithelial cells. J. Cell Biochem. 2002, 87, 29-38.
15. Fukuda, K., Kojiro, M., Chiu, J. F., Induction of apoptosis by transforming growth factor-beta 1 in the rat hepatoma cell line McA-RH7777: A possible association with tissue transglutaminase expression. Hepatology 1993, 18, 945-953.
16. Langard, S., Chromium carcinogenicity; a review of experimental animal data. Sci. Total Environ. 1988, 71, 341-350.
17. Leonard, A., Lauwerys, R. R., Carcinogenicity and mutagenicity of chromium. Mutat. Res. 1980, 76, 227-239.
18. Gaggelli, E., Berti, F., D'Amelio, N., Gaggelli, N. et al., Metabolic pathways of carcinogenic chromium. Environ. Health Perspect. 2002, 110, 733-738.
19. Levina, A., Codd, R., Dillon, C. T., Lay, P. A., Chromium in biology: Toxicology and nutritional aspects. Prog. Inorg. Chem. 2003, 51, 145-250.
20. O'Brien, T. J., Ceryak, S., Patierno, S. R., Complexities of chromium carcinogenesis: Role of cellular response, repair and recovery mechanisms. Mutat. Res. 2003, 533, 3-36.
21. Ding, M., Shi, X., Molecular mechanisms of Cr(VI)-induced carcinogenesis. Mol. Cell Biochem. 2002, 234-235, 293-300.
22. Ha, L., Ceryak, S., Patierno, S. R., Generation of S phase-dependent DNA double-strand breaks by Cr(VI) exposure: Involvement of ATM in Cr(VI) induction of gamma-H2AX. Carcinogenesis 2004, 25, 2265-2274.
23. Muranaka, S., Kanno, T., Fujita, H., Kobuchi, H. et al., Involvement of ceramide in the mechanism of Cr(VI)-induced apoptosis of CHO Cells. Free Radic. Res. 2004, 38, 613-621.
24. Quievryn, G., Peterson, E., Messer, J., Zhitkovich, A., Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. Biochemistry 2003, 42, 1062-1070.
25. O'Brien, T. J., Fornsaglio, J. L., Ceryak, S., Patierno, S. R., Effects of hexavalent chromium on the survival and cell cycle distribution of DNA repair-deficient S. cerevisiae. DNA Repair (Amst.) 2002, 1, 617-627.
26. Yang, P. H., Gao, H. Y., Cai, J., Chiu, J. F. et al., The stepwise process of chromium-induced DNA breakage: characterization by electrochemistry, atomic force microscopy, and DNA electrophoresis. Chem. Res. Toxicol. 2005, 18, 1563-1566.
27. Boulos, S., Meloni, B. P., Arthur, P. G., Majda, B. et al., Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury. Neurobiol. Dis. 2007, 25, 54-64.
28. Shi, X., Mao, Y., Knapton, A. D., Ding, M. et al., Reaction of Cr(VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: Role of a Cr(IV)-mediated fenton-like reaction. Carcinogenesis 1994, 15, 2475-2478.
29. Stearns, D. M., Kennedy, L. J., Courtney, K. D., Giangrande, P. H. et al., Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry 1995, 34, 910-919.
30. Bagchi, D., Bagchi, M., Stohs, S. J., Chromium (VI)-induced oxidative stress, apoptotic cell death and modulation of P53 tumor suppressor gene. Mol. Cell Biochem. 2001, 222, 149-158.
31. Ye, J., Wang, S., Leonard, S. S., Sun, Y. et al., Role of reactive oxygen species and P53 in chromium(VI)-induced apoptosis. J. Biol. Chem. 1999, 274, 34974-34980.
32. Carlisle, D. L., Pritchard, D. E., Singh, J., Owens, B. M. et al., Apoptosis and P53 induction in human lung fibroblasts exposed to chromium (VI): Effect of ascorbate and tocopherol. Toxicol. Sci. 2000, 55, 60-68.
33. Gambelunghe, A., Piccinini, R., Abbritti, G., Ambrogi, M. et al., Chromium VI-induced apoptosis in a human bronchial epithelial cell line (BEAS-2B) and a lymphoblastic leukemia cell line (MOLT-4). J. Occup. Environ. Med. 2006, 48, 319-325.
34. Ye, J., Zhang, X., Young, H. A., Mao, Y. et al., Chromium(VI)-induced nuclear factor-kappa B activation in intact cells via free radical reactions. Carcinogenesis 1995, 16, 2401-2405.
35. Chen, F., Bower, J., Leonard, S. S., Ding, M. et al., Protective roles of NF-kappa B for chromium(VI)-induced cytotoxicity is revealed by expression of Ikappa B kinase-beta mutant. J. Biol. Chem. 2002, 277, 3342-3349.
36. Kim, Y. D., An, S. C., Oyama, T., Kawamoto, T. et al., Oxidative stress, Hogg1 expression and NF-kappaB activity in cells exposed to low level chromium. J. Occup. Health 2003, 45, 271-277.
37. Chen, F., Ding, M., Lu, Y., Leonard, S. S. et al., Participation of MAP kinase P38 and IkappaB kinase in chromium (VI)-induced NF-kappaB and AP-1 activation. J. Environ. Pathol. Toxicol. Oncol. 2000, 19, 231-238.
38. Chuang, S. M., Liou, G. Y., Yang, J. L., Activation of JNK, P38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis 2000, 21, 1491-1500.
39. Gao, N., Jiang, B. H., Leonard, S. S., Corum, L. et al., P38 signaling-mediated hypoxia-inducible factor 1alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J. Biol. Chem. 2002, 277, 45041-45048.